ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,539Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 633

$743K Total Retail Price of All Prescriptions

Rank: 21 out of 633

571 Patients Receiving at Least One Drug in Part D
83% Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nebraska
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

12% of this provider’s 571 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 571 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 770 666 120 1 1
WARFARIN SODIUM 519 485 65 2 7
HYDROCODONE-ACETAMINOPHEN 499 288 92 S3 3 8
AMLODIPINE BESYLATE 449 427 67 4 4
OMEPRAZOLE 412 328 63 5 2
SIMVASTATIN 390 367 64 6 3
METOPROLOL SUCCINATE 383 338 65 7 13
FUROSEMIDE 355 334 64 8 6
POTASSIUM CHLORIDE 343 296 59 9 11
METOPROLOL TARTRATE 322 274 46 10 12
LISINOPRIL 303 275 47 11 5
PANTOPRAZOLE SODIUM 259 219 43 12 28
GLIMEPIRIDE 244 193 32 13 38
TAMSULOSIN HCL 225 210 32 14 24
ALLOPURINOL 221 216* 36 15 25
RANITIDINE HCL 207 127 31 16 45
OXYCODONE HCL 201 105 28 S2 17 121
MONTELUKAST SODIUM 199 108 32 18 59
GABAPENTIN 191 141 46 19 16
CLOPIDOGREL 183 158 30 20 30
LOSARTAN POTASSIUM 175 170* 27 21 17
QUETIAPINE FUMARATE 169 141 24 A 22 57
LORAZEPAM 167 119 30 B 23 37
FENTANYL 166 143 23 S2 24 46
ATORVASTATIN CALCIUM 163 118 26 25 9
SERTRALINE HCL 160 155* 20 26 19
METFORMIN HCL 159 154* 29 27 10
TRAMADOL HCL 150 135 42 28 15
POLYETHYLENE GLYCOL 3350 146 141* 31 29 29
ISOSORBIDE MONONITRATE ER 144 139* 24 30 58
PRAVASTATIN SODIUM 139 109 26 31 21
MELOXICAM 139 105 32 31 23
TRIAMTERENE-HCTZ 134 112 16 33 49
HYDROCHLOROTHIAZIDE 131 116 25 34 14
ALPRAZOLAM 130 92 24 B 35 32
CARVEDILOL 129 124* 19 36 18
ATENOLOL 127 111 24 37 22
ZOLPIDEM TARTRATE 127 84 35 37 26
DETROL LA 124 <11 <11 39 104
PREDNISONE 123 95 32 40 36
LYRICA 121 95 20 41 81
CRESTOR 115 110* 20 42 27
DONEPEZIL HCL 114 114 16 43 33
CEPHALEXIN 112 95 69 44 72
CYMBALTA 111 84 11 45 41
NAMENDA 103 <11 <11 46 34
FAMOTIDINE* 102 88 19 47 66
TRAZODONE HCL 102 29 20 47 48
CITALOPRAM HBR 100 80 12 49 20
BENAZEPRIL HCL 99 94* 15 50 50
SPIRONOLACTONE 99 94* 17 50 44
NEXIUM 98 77 11 52 47
NAPROXEN 98 86 24 52 104
ROPINIROLE HCL 97 85 17 54 63
TEMAZEPAM 93 78 15 B 55 166
OXYCONTIN 92 53 11 S2 56 134
MIRTAZAPINE 92 87* 11 56 56
LOSARTAN-HYDROCHLOROTHIAZIDE 80 80 11 58 43
FENOFIBRATE* 79 <11 <11 59 60
DIOVAN 78 <11 <11 60 52
VENLAFAXINE HCL ER 77 66 13 61 73
JANUVIA 76 <11 <11 62 97
PHENYTOIN SODIUM EXTENDED 72 <11 <11 63 145
BYSTOLIC 72 72 16 63 55
MORPHINE SULFATE ER 72 <11 <11 S2 63 126
BACLOFEN 69 <11 <11 66 136
CELEBREX 68 51 14 67 61
RAMIPRIL 66 <11 <11 68 77
AMITRIPTYLINE HCL 64 <11 <11 R 69 71
FLUTICASONE PROPIONATE 62 57* 19 70 39
SYMBICORT 62 36 15 70 119
TIZANIDINE HCL 62 <11 <11 70 149
PIOGLITAZONE HCL 61 <11 <11 R 73 62
DOXAZOSIN MESYLATE 61 61 11 73 86
PAROXETINE HCL 60 <11 <11 75 74
OXYBUTYNIN CHLORIDE ER 60 <11 <11 75 107
FLUOXETINE HCL 60 <11 <11 75 78
AGGRENOX 58 <11 <11 78 133
CIPROFLOXACIN HCL 55 50* 34 79 75
ALENDRONATE SODIUM 54 49* 13 80 35
CARBIDOPA-LEVODOPA 54 <11 <11 80 89
LANTUS 54 35 15 80 53
AMLODIPINE BESYLATE-BENAZEPRIL 53 <11 <11 83 101
VALSARTAN-HYDROCHLOROTHIAZIDE 52 <11 <11 84 92
AMIODARONE HCL 51 <11 <11 85 148
DILANTIN* 50 <11 <11 86 325
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 25, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.